Hot off the heels of Angelina Jolie’s mastectomy decision – due to being BRCA mutation positive – a June 13, 2013 decision by the Supreme Court now rules that human genes cannot be patented. The debate regarding DNA ownership centers heavily on Myriad Genetics, which was awarded patents for BRCA1 and BRCA2 mutations (actual patents on DNA sequences) in the 1990s. The gates are now open for others to offer BRCA1/2 testing for reduced prices, an opportunity companies are already capitalizing on within a mere 24 hours of the ruling.
- Justice Strikes Down on Gene Patents
- Court Ruling May Open Up Breast Cancer Gene Tests
- U.S. Supreme Court Strikes Down Human Gene Patents
- Ambry Launches BRCA1/2